About 6 in 10 people say they probably won’t get an updated shot this year, despite the CDC’s recommendation that everyone do so, according to results of a new survey from the Pew Research Center.

More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.